prikaz prve stranice dokumenta Role of H. pylori eradication therapy success on five year dynamics of dysplasia
  Download
PDF 693.07 KB
Scientific paper - Conference abstract (invited lecture)
Role of H. pylori eradication therapy success on five year dynamics of dysplasia
In: Abstracts: 24th International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer. Wiley, 2011. pp. 80. https://doi.org/10.1111/j.1523-5378.2011.00886.x
Filipec Kanizaj, Tajana; Katicic, Miroslava; Skurla, Bruno; Prskalo, Marija; Colic Cvrlje, Vesna; Naumovski Mihalic, Slavica; Mrzljak, Anna; Bradic, Tihomir; Sobocan, Nikola

Institutional repository: Merkur University Hospital Repository

Cite this document

Filipec Kanizaj, T., Katicic, M., Skurla, B., Prskalo, M., Colic Cvrlje, V., Naumovski Mihalic, S. ... Sobocan, N. (2011). Role of H. pylori eradication therapy success on five year dynamics of dysplasia. Abstracts: 24th International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer (p. 80). Wiley. doi: 10.1111/j.1523-5378.2011.00886.x

Filipec Kanizaj, Tajana, et al. "Role of H. pylori eradication therapy success on five year dynamics of dysplasia." Abstracts: 24th International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer, Wiley, 2011, p. 80. https://urn.nsk.hr/urn:nbn:hr:264:684291

Filipec Kanizaj, Tajana, Miroslava Katicic, Bruno Skurla, Marija Prskalo, Vesna Colic Cvrlje, Slavica Naumovski Mihalic, Anna Mrzljak, Tihomir Bradic and Nikola Sobocan. "Role of H. pylori eradication therapy success on five year dynamics of dysplasia." In Abstracts: 24th International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer, 80. Wiley, 2011. Accessed 2024 April 30. https://urn.nsk.hr/urn:nbn:hr:264:684291

Filipec Kanizaj, T., et al. (2011) 'Role of H. pylori eradication therapy success on five year dynamics of dysplasia', Abstracts: 24th International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer, Wiley, p. 80. Available at: https://urn.nsk.hr/urn:nbn:hr:264:684291 (Accessed 30 April 2024)

Filipec Kanizaj T, Katicic M, Skurla B, Prskalo M, Colic Cvrlje V, Naumovski Mihalic S, and sur.. Role of H. pylori eradication therapy success on five year dynamics of dysplasia. Abstracts: 24th International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer. Wiley; 2011. Pp. 80-80. [cited 2024 April 30] Available at: https://urn.nsk.hr/urn:nbn:hr:264:684291

T. Filipec Kanizaj, et al., "Role of H. pylori eradication therapy success on five year dynamics of dysplasia", Abstracts: 24th International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer Wiley, 2011. [Online] Available at: https://urn.nsk.hr/urn:nbn:hr:264:684291 [Accessed: 30 April 2024]

Metadata
Title (english)Role of H. pylori eradication therapy success on five year dynamics of dysplasia
AuthorTajana Filipec Kanizaj
AuthorMiroslava Katicic
AuthorBruno Skurla
AuthorMarija Prskalo
AuthorVesna Colic Cvrlje
AuthorSlavica Naumovski Mihalic
AuthorAnna Mrzljak
AuthorTihomir Bradic
AuthorNikola Sobocan
Author's institution(Merkur University Hospital)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
Aim: to investigate the role of eradication therapy success on five year dynamics of dysplasia. Materials and methods: study was performed on 41 H. pylori positive patients with dysplasia in basic bioptic specimens analyzed according to updated Sydney protocol. All patients received triple eradication therapy. Therapy success and dynamics of dysplasia were evaluated according to 5th year histological finding. Results: basically 41 patients had dysplasia in corpus and/or antrum. Grade I 7, 31%, grade II 39, 02% and grade III 53, 65% of patients. H. pylori was successfully eradicated in 37 patients (90, 24%). In successfully eradicated, complete regression of dysplastic changes appeared in 33/37 (90, 89%) of patients. In all of rest 3 eradicated patients regression of grade of dysplasia was observed. In 2 of 4 non- eradicated patients complete regression of dysplasia and for rest 2 only regression of grade of dysplasia appeared. Statistically significant dynamics of grade of dysplasia was observed for successfully eradicated patients (Wilcox rank sum test, p<0, 001). The difference in proportion of patients with complete regression of dysplasia between eradicated and non - eradicated is statistically significant. Conclusions: In five year interval, proportion of patents with complete regression of dysplasia is statistically significantly higher in successfully eradicated patients than non- eradicated. In both groups regression of grade of dysplasia (and no progression) was observed with application of eradication therapy.
Keywords (english)
Languageenglish
Publication typeScientific paper - Conference abstract (invited lecture)
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Publication titleAbstracts: 24th International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer
EditionHelicobacter
Numberingvol. 16, no. suppl. 1, p. 80
e-ISSN1523-5378
DOIhttps://doi.org/10.1111/j.1523-5378.2011.00886.x
URN:NBNurn:nbn:hr:264:684291
Online first2011-09-07
ConferenceTitle: XXIVth International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer
Location: Dublin, Ireland
Organizer: European Helicobacter Study Group
Start date: 2011-09-11
End date: 2011-09-13
Assembly type: Lecture
Document URLhttps://onlinelibrary.wiley.com/toc/15235378/2011/16/s1
Type of resourceText
PublisherWiley
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2021-07-30 09:34:27